The cartridge was not received for evaluation.Log files were received and analyzed which showed treatment on the date of the event was unremarkable with no evidence of a product deficiency.Photos of the device were received and reviewed and no malfunction was identified.The photos show the that the cartridge heparin line was improperly clamped and lacked occlusion, indicating the blood loss likely occurred from this location.A review of the device history record (dhr) was conducted which confirmed the device met all quality criteria and manufacturing specifications prior to release.The nxstage system one user guide and car-172-c instructions for use (ifu) provide information and warnings for use of the device.The ifu warns to always visually inspect the package and product before use, and to not use any supplies after their expiration date.A trained and qualified person must observe all treatments, check the system for blood and fluid leaks during treatment and pay close attention to the bloodline and access connections.The documentation warns to make sure all manual connections are secure and fluid tight before starting treatment, and to secure caps and close clamps after priming and after each use.
|